Fred (Farhad) Khosravi is the Chairman and CEO of Imperative Care and sits on the board of NeuroLutions. Fred is also the Managing Director of Incept LLC, an Innovations Accelerator. Together, Incept has founded or co-founded twenty-three innovative startup companies with fourteen exits including to IPO, Boston Scientific, Medtronic, Cardinal Health and Teleflex, among others. Incepts companies have developed products that treat over a million patients worldwide every year. Prior to his entrepreneurial career, Fred was Engineering Manager in the initial management team at Focal, Inc. (acquired by Genzyme Biosurgery), responsible for its cardiovascular products. He was also the Business Unit Manager of the Stent Business at Guidant/ACS where he led the initial design and development team of the highly successful Multilink stent. Prior to ACS (from 1986 through 1989) he held several management positions with Alcon Surgical. Fred is the author or co-author on over 40 medical device patents. Fred has a B.S. degree in Mechanical Engineering and graduated cum laude, obtaining a Master of Science degree in Mechanical Engineering from Tennessee Tech University.
Current role